{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:56:57Z","timestamp":1778939817979,"version":"3.51.4"},"reference-count":29,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:p>Background: HbS\/b cases having clinical, hematologic and electrophoretic similarities cannot be sufficiently distinguished from sickle cell anemia cases and are misdiagnosed as sickle cell anemia. This study will investigate the congruence between the HPLC thalassemia scanning tests and the laboratory findings compared to the DNA sequence analysis results of the patients diagnosed with SCA between 2016 and 2020. This study also aims to indicate the current status to accurately diagnose sickle cell anemia and HbS\/b in the light of hematologic, electrophoretic and molecular studies. Methods: Fourteen patients who were diagnosed with SCA in hospitals at different cities in Turkey and followed by the Thalassemia Diagnosis, Treatment and Research Center, Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University were included in this retrospective study. The socio-demographic characteristics, hemogram, hemoglobin variant analysis results and DNA chain analysis results of the patients were taken from the database of the centre and then examined. The informed consents were taken from the patients. The patients were administered a survey containing questions about transfusion history and diagnostic awareness. The Beta-Thalassemia mutations were analysed using a DNA sequencer (Dade Behring, Germany) based on the Sanger method. Results: According to the DNA sequence analysis, the results of these patients diagnosed with SCA in hospitals in different cities of Turkey were the following: of 14 patients, 8 had HbS\/b0, and HbS\/b+ and one had HbS carrier, and one had Hb-O, and three had SCA. The patient with HbS carrier status also contains three additional mutations, all of which are heterozygous. We discovered that although two of three mutations, which are c.315+16G&gt;C and c.316-185C&gt;T, are previously reported as benign, at least one of the two mentioned mutations, when combined with HbS, causes transfusion-dependent HbS\/b. Conclusions: Briefly, HbSS and HbS\/b thalassemia genotypes cannot be definitely characterized by electrophoretic and hematologic data, resulting in misdiagnosis. c.315+16G&gt;C and c.316-185C&gt;T are previously reported as benign; at least one of the two mentioned mutations, when combined with HbS, causes transfusion-dependent HbS\/b. In undeveloped or some developing countries, molecular diagnosis methods and genetic analyses cannot be used. If mutation analyses could be performed, then such differential diagnosis errors would reduce. However, if mutation analysis cannot be performed, other methods such as HPLC, capillary electrophoresis absolutely be sought to have insight into the parental carriage status.<\/jats:p>","DOI":"10.5937\/jomb0-30420","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T15:20:47Z","timestamp":1622215247000},"page":"32-39","source":"Crossref","is-referenced-by-count":12,"title":["Difficulties in the diagnosis of HbS\/beta thalassemia: Really a mild disease?"],"prefix":"10.5937","volume":"41","author":[{"given":"S\u00fcheyl","family":"U\u00e7ucu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha","family":"Karab\u0131y\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Azik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","unstructured":"Ashorobi D, Bhatt R. Sickle Cell Trait. StatPearls. Treasure Island (FL): StatPearls Publishing, Copyright \u00a9 2020, StatPearls Publishing LLC.; 2020;"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Medicine 2013; 10(7): e1001484;","DOI":"10.1371\/journal.pmed.1001484"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hazzazi AA, Ageeli MH, Alfaqih AM, Jaafari AA, Malhan HM, Bakkar MM. Epidemiology and characteristics of sickle cell patients admitted to hospitals in Jazan region, Saudi Arabia. Journal of Applied Hematology 2020; 11(1): 10;","DOI":"10.4103\/joah.joah_67_19"},{"key":"ref4","unstructured":"Maakaron JE, Besa E. Sickle cell anemia. Medscape Reference (software). 2013;"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bain BJ. Haemoglobinopathy diagnosis: John Wiley & Sons; 2020;","DOI":"10.1002\/9781119579977"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Thein SL. Molecular basis of b thalassemia and potential therapeutic targets. Blood Cells, Molecules, and Diseases 2018; 70: 54-65;","DOI":"10.1016\/j.bcmd.2017.06.001"},{"key":"ref7","unstructured":"Derne\u011fi TH. Eritrosit Hastal\u0131klar\u0131 Ve Hemoglobin Bozukluklar\u0131 -Orak H\u00fccre Anemisi Tan\u0131 ve Tedavi K\u0131lavuzu. Ulusal Tan\u0131 Ve Tedavi K\u0131lavuzu 2019; 1.1: 52;"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Belis\u00e1rio AR, Carneiro-Proietti AB, Sabino EC, Ara\u00fajo A, Loureiro P, M\u00e1ximo C, et al. Hb S\/-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Labo ratory and Molecular Characteristics. Hemoglobin 2020: 1-9;","DOI":"10.1080\/03630269.2020.1731530"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Saraf SL, Molokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GJ, et al. Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatric respiratory reviews 2014; 15(1): 4-12;","DOI":"10.1016\/j.prrv.2013.11.003"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Figueiredo MS. The compound state: Hb S\/beta-thalassemia. Revista brasileira de hematologia e hemoterapia 2015; 37 (3): 150-2;","DOI":"10.1016\/j.bjhh.2015.02.008"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Rees DC, Gibson JS. Biomarkers in sickle cell disease. British Journal of Haematology 2012; 156(4): 433-45;","DOI":"10.1111\/j.1365-2141.2011.08961.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Notarangelo LD, Agostini A, Casale M, Samperi P, Arcioni F, Gorello P, et al. HbS\/+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation. Eur J Haematol 2020; 104(3): 214-22;","DOI":"10.1111\/ejh.13362"},{"key":"ref13","unstructured":"Christopher McKinney M, Rachelle Nuss, MD, Kathryn L. Hassell M. Sickle Cell Disease 2017;"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Giardine B BJ, Viennas E, Pavlidis C, Moradkhani K, Joly P, Bartsakoulia M, Riemer C, Miller W, Tzimas G, Wajc man H, Hardison RC, Patrinos GP. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res 2014 Jan; 42 (Database issue): D1063-9;","DOI":"10.1093\/nar\/gkt911"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Aslam AF, Dipillo F, Aslam AK. Fatal splenic sequestration crisis with multiorgan failure in an adult women with sickle cell-beta + thalassemia. The American Journal of Medical Science 2005; 329(3): 141-3;","DOI":"10.1097\/00000441-200503000-00006"},{"key":"ref16","unstructured":"Elaine M. Keohane CNOaJMW. Rodak's Hematology Clinical Principles and Applications. Book, 6th Edition 2020;"},{"key":"ref17","unstructured":"Belgemen \u00d6zer T, Axdin K\u00f6ker S, Ocak S et al. \u00dclkemizde \u0130zlenen Orak H\u00fccre-Beta Talasemi Olgular\u0131n\u0131n \u00c7ok Merkezli De\u011ferlendirilmesi: TPHD Hemo globinopati \u00c7al\u0131\u015fma Grubu Sonu\u00e7lar\u0131, 12. Ulusal Pediatrik Hematoloji Kongresi, Konya, Turkey 2019: 92-3;"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Benites BD, Bastos SO, Baldanzi G, dos Santos AdO, Ramos CD, Costa FF, et al. Sickle cell\/-thalassemia: comparison of Sb0 and Sb+ Brazilian patients followed at a single institution. Hematology 2016; 21: 623-9;","DOI":"10.1080\/10245332.2016.1187843"},{"key":"ref19","unstructured":"Bender M. Sickle Cell Disease. 2003 Sep 15 (updated 2017 Aug 17). GeneReviews\u00ae (Internet) Seattle (WA): University of Washington, Seattle. 2017;"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"DeBaun M, Jordan L, King A, Schatz J, Vichinsky E, Fox C, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood advances 2020; 4: 1554-88;","DOI":"10.1182\/bloodadvances.2019001142"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Belis\u00e1rio AR, Sales RR, Viana MB. Very mild forms of Hb S\/beta+-thalassemia in Brazilian children. Revista Brasileira de Hematologia e Hemoterapia 2015; 37: 198-201;","DOI":"10.1016\/j.bjhh.2015.03.010"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Belis\u00e1rio AR, Carneiro-Proietti AB, Sabino EC, Ara\u00fajo A, Loureiro P, M\u00e1ximo C, et al. Hb S\/-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics 2020: 1-9;","DOI":"10.1080\/03630269.2020.1731530"},{"key":"ref23","unstructured":"Dawling S. Anemia Associated with Hemoglobin S-Beta Thalassemia. Cancer Therapy Advisor 2019;"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Phylipsen M, Gallivan M, Arkesteijn S, Harteveld C, Giordano P. Occurrence of common and rare globin gene defects in two multiethnic populations: thirteen new mutations and the significance of globin gene defects in b thalassemia diagnostics. International Journal of Laboratory Hematology 2011; 33: 85-91;","DOI":"10.1111\/j.1751-553X.2010.01255.x"},{"key":"ref25","unstructured":"\u00c7a\u011fla Er\u00f6z FMA, Volkan Karaku\u015f. Orak h\u00fccreli anemiden beta talasemi intermediaya: kay\u0131tl\u0131 her tan\u0131 sorgulanmaya muhta\u00e7t\u0131r. Ulusal Hematoloji Kongresi 2017; 43: 267;"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Edo-Osagie E, Enofe I, Hakeem H, Rai M, Adomako E, Tismenetsky M, et al. Splenic sequestration crisis as an index manifestation of heterozygous hemoglobinopathy in an adult. Oxford Medical Case Reports 2019; (7): omz069;","DOI":"10.1093\/omcr\/omz069"},{"key":"ref27","unstructured":"Ashorobi D, Bhatt R. Bone marrow transplantation in sickle cell disease. StatPearls (Internet): StatPearls Publishing; 2019;"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Al-Salem AH, Qaisaruddin S, Nasserallah Z, Al Dabbous I, Al Jam'a A. Splenectomy in patients with sickle-cell disease. American Journal of Surgery 1996; 172(3): 254-8;","DOI":"10.1016\/S0002-9610(96)00158-4"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Yadav R, Lazarus M, Ghanghoria P, Singh MP, Gupta RB, Kumar S, et al. Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals. Hematology 2016; 21: 558-63;","DOI":"10.1080\/10245332.2016.1148893"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Te\u0161ko\u0107e u dijagnozi HbS-beta talasemije - zaista blaga bolest?"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2022\/1452-82582201032U.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T18:39:13Z","timestamp":1643827153000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582201032U"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-30420","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}